Adastra Labs Holdings Ltd. is comprised of Adastra Labs Inc., a Health Canada Standard Processing (Extracts) licence applicant since October 2018 and Chemia Analytics Inc., a licensed cannabis analytical testing ab beginning initial operations. These wholly-owned subsidiaries are co-located in a 13,000 sq ft, owned GMP-compliant facility in the British Columbia Lower mainland outside Langley. Adastra Labs is submitting its fully-renovated facility evidence package to Health Canada in November 2019 and was designed to process over 400,000 kg dried cannabis a year producing over 30,000 litres of highly refined cannabis oil distillate. Chemia will provide the full spectrum of cannabis testing services to the Canadian cannabis market and its sister company Adastra Labs. The entire enterprise is conditionally approved for listing on the Canadian Securities Exchange with a Reverse Take-Over transaction later in November 2019.